• Psychedelics - assisted psychotherapy in


    Despite the huge therapeutic potential, psychedelic-assisted psychotherapy is not part of Maryland standard medical care yet. Self-medicating with psychedelics can produce undesired results, but despite that, more and more people feel disappointed with the efficacy of the current treatments and they turn to risky, but potentially more beneficial psychedelic-assisted therapy. The goal of this guide is harm reduction for people, who decided to self-medicate, we don’t encourage possession or consumption of illicit substances even for therapeutic endeavours.

    Book a video consultation Psychedelic integration

Psychedelics – assisted psychotherapy in Maryland

Legal status of psychedelics in Maryland

Possession of other drugs than Cannabis can lead to severe penalties, depending on the amounts of a substance and whether intent to distribute is established. Possession of a controlled substance is a misdemeanor, punishable by up to four years in prison and a fine of up to $25,000. The sum of a drug and the defendant’s criminal record are used to determine the crime and punishment if convicted.

If you are found in possession of hallucinogens, you will face a felony charge. The maximum potential sentence applies to drugs like ecstasy and LSD.

There are no clear rules in Maryland when it comes to who gets probation and who doesn’t. There are no guarantee of a  second chance here.

The safest way to obtain psychedelics in Maryland

Purchasing, possessing, and transporting magical mushroom spores are all legal in Maryland. Magic mushroom spores are available from a variety of online shops and vendors. Growing psilocybin mushrooms, on the other hand, is still illegal. It is illegal to own, sell, or transport mushrooms once they are mature enough to produce natural psilocybin.

Maryland is right next to Washington, D.C., which is debating whether or not to decriminalize psilocybin. This might or may not have an effect on Maryland’s public and legal perceptions of magic mushrooms. For the time being, people cannot possess, sell, or transport any psilocybin-containing mushrooms.

It’s really ironic that Maryland – home to the world’s leading psychedelic research center, the Johns Hopkins Center for Psychedelic & Consciousness Research, which opened in 2019, still classifies psilocybin as a Schedule I substance that can’t be used therapeutically.

The efficacy of psilocybin as a new medication for opioid addiction, Alzheimer’s disease, PTSD, post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol usage in people with major depression will be determined in upcoming research. The researchers hope to develop precision medicine therapies that are personalized to and patient’s unique needs.